Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

47 results about "Ethyl linoleate" patented technology

Ethyl linoleate is a long-chain fatty acid ethyl ester resulting from the formal condensation of the carboxy group of linoleic acid with the hydroxy group of ethanol.It has a role as a plant metabolite and an anti-inflammatory agent.

Method for preparating ethyl linoleate by catalysis of composite solid ultra-strong acid

The present invention is a method of preparing the linoleic acid ethyl ester with the composite solid superacid catalyst. The production method the of linoleic acid ethyl ester in the existing industrialized production is the esterification reaction between the linoleic acid and the anhydrous ethanol ester with the concentrated sulfuric acid as the catalyst. The method has the problems of the large discharge of the acidic wastewater, the serious corrosion of the production equipment and so on. Therefore, the industrialized production urgently needs an environment-friendly solid acid catalyst. The method of preparing the linoleic acid ethyl ester with the composite solid superacid catalyst of the present invention is that the linoleic acid and the anhydrous ethanol with the molar ratio of 1 to between 1 and 10 are added into the reactor in order; the mixed solution is added with the SO42-/TiO2-SiO2, the composite solid superacid catalyst, whose weight is 1 to 10 percent of the weight of the linoleic acid; the mixed solution is stirred and heated with the protection of the nitrogen; the reaction is done for 2 to 10 hours at the return temperature of 40 DEG C; the solution is delaminated statically after the reaction; the products on the upper layer are decompressed and distilled under the pressure of minus 98.8 to minus 99.3 kPa; the distilled ingredients are collected at the temperature between 162 and 172 DEG C; then the refined inoleic acid ethyl ester can be got. The method of the present invention is suitable for the preparation of the linoleic acid ethyl ester in the industry.
Owner:HEILONGJIANG UNIV

Attractant for carpomya-vesuviana-costa adult and application thereof

The invention discloses an attractant for a carpomya-vesuviana-costa adult and application thereof. The attractant is prepped from one or more of myristic acid, ethyl myristate, ethyl laurate, ethyl palmitate, a mixture, ethyl linoleate and ethyl oleate. When the attractant is applied, different formulas of the attractant are provided aiming at carpomya-vesuviana-costa male adult and female adult; a jujube-fruit volatile matter is adopted as the attractant and used by matching with a yellow insect sticky trap; the attractant has the characteristics of being good in attraction effect and high in specificity and having no adverse influences on an environment; the attraction activity, to carpomya vesuviana costa, of six substances in the formulas are tested respectively with a four-arm olfactometer; shown by results, the female carpomya vesuviana costa has higher selection rates, which are all 30 percent or above, to the ethyl palmitate, the ethyl laurate and the myristic acid; the male carpomya vesuviana costa has higher selection rates, which are all 25 percent or above, to the ethyl linoleate and the ethyl oleate. Through continuous 8d monitoring in field, the attraction effect of the volatile matter myristic acid is better; the maximum trapping quantity is up to 23 carpomya-vesuviana-costa adults per trapper and the average trapping quantity is 18.2 carpomya-vesuviana-costa adults per trapper.
Owner:中捷四方(新疆)生物科技有限公司

Gamithromycin emulsion, preparation method thereof and application of gamithromycin emulsion in prevention and treatment of porcine ileitis

The invention relates to a gamithromycin emulsion. Each 100g of the gamithromycin emulsion comprises the following components by weight of 0.01 to 5.0 g of gamithromycin, 0.1 to 16.0 g of lysimachia christinae hance oil, 0.1 to 5.0 g of ethyl linoleate, 8.0 to 30.0 g of sucrose fatty acid ester, 10.0 to 20.0 g of polyoxyethylene ether (60) hydrogenated castor oil, 5.0 to 10.0 g of 1, 2-propylene glycol and the balance of deionized water. Meanwhile, the invention further discloses a preparation method, the process operability is high, and production conversion is facilitated. The emulsion disclosed by the invention is in an oil-water mutual wrapping type, the prepared product can be infinitely diluted with water and can also be infinitely diluted with oil, after being diluted with water, the emulsion can meet the drinking water administration requirement and is convenient to use, and after being diluted with oil, the emulsion can be prepared into a slow-release emulsion, so that a long-acting antibacterial effect is achieved, and the administration frequency is reduced. The emulsion disclosed by the invention can be used for preventing and treating ileitis diseases caused by pig Lawsonia intracellularis infection, has an effect obviously better than that of the prior art, and has a wide market application prospect.
Owner:项朝荣

Esterification-ultrahigh pressure crystallization separation method for distillate of vegetable oil

An esterification-ultrahigh pressure crystallization separation method for a distillate of vegetable oil takes the distillate of vegetable oil as a raw material, comprises the various unit processes of esterifying, crystalizing, separating, desolventizing, washing and drying, and is characterized in that: in the esterifying process, concentrated sulfuric acid is taken as a catalyst, and absolute ethyl alcohol and free fatty acid are subject to esterification reaction at the temperature of 80 DEG C for 1 hour; in the crystalizing process, urea and 95% ethyl alcohol are added into an esterifying solution, the mixture is stirred to be dissolved, injected into a soft packaging bag, pumped and sealed, and then put into an ultrahigh pressure container to be processed at the pressure of 100-600MPa for 0.5-1h, then the pressure is released, the bag is unpacked, and the operations of separating, desolventizing, washing and drying are conducted to obtain a product mainly containing unsaturated fatty acid ethyl ester, VE, squalene, phytosterol and neutral oil. According to the method, the recovery rate of VE is equal to or larger than 90%, the recovery rate of phytosterol is equal to or larger than 60%, the recovery rate of squalene is equal to or larger than 70%, the recovery rate of neutral oil is equal to or larger than 90%, and the recovery rate of ethyl linoleate is equal to or larger than 80%.
Owner:潘见

Mild type makeup removing lotion and preparation method thereof

The invention discloses mild type makeup removing lotion and a preparation method thereof and belongs to the technical field of cosmetics. The mild type makeup removing lotion takes linseed oil and camellia seed oil as raw materials to form a water-in-oil stable makeup removing lotion base material structure, and has anti-acne, anti-inflammatory and sunscreen effects; meanwhile, emulsified oil hasthe property of easiness of being dissolved into water, so that dirt on faces can be washed and cleaned only if the emulsified oil is washed with clean water; conjugated ethyl linoleate is used as animprinted molecule for carrying out immobilization on aspergillus oryzae lipase; then the conjugated ethyl linoleate is added to be subjected to catalytic reaction with lecithin, so that the catalytic conversion efficiency is promoted and a phospholipid moisturizing and repairing activating agent is formed, and furthermore, stimulating behaviors of the makeup removing lotion on skin surfaces arereduced; ursolic acid and glycyrrhizic acid are introduced to protect keratin on the skin surfaces in a makeup removing process, so that the irritation on skin is the smallest; antibacterial protection on the makeup removing lotion also can be formed and the skin is prevented from being injured by spoiled lotion. By adopting the mild type makeup removing lotion, the problems of current makeup removing lotion that the irritation on the skin is relatively great and the makeup removing efficiency is low are solved.
Owner:高昕文

A kind of esterification-ultrahigh pressure crystallization separation method of vegetable oil distillate

An esterification-ultrahigh pressure crystallization separation method for a distillate of vegetable oil takes the distillate of vegetable oil as a raw material, comprises the various unit processes of esterifying, crystalizing, separating, desolventizing, washing and drying, and is characterized in that: in the esterifying process, concentrated sulfuric acid is taken as a catalyst, and absolute ethyl alcohol and free fatty acid are subject to esterification reaction at the temperature of 80 DEG C for 1 hour; in the crystalizing process, urea and 95% ethyl alcohol are added into an esterifying solution, the mixture is stirred to be dissolved, injected into a soft packaging bag, pumped and sealed, and then put into an ultrahigh pressure container to be processed at the pressure of 100-600MPa for 0.5-1h, then the pressure is released, the bag is unpacked, and the operations of separating, desolventizing, washing and drying are conducted to obtain a product mainly containing unsaturated fatty acid ethyl ester, VE, squalene, phytosterol and neutral oil. According to the method, the recovery rate of VE is equal to or larger than 90%, the recovery rate of phytosterol is equal to or larger than 60%, the recovery rate of squalene is equal to or larger than 70%, the recovery rate of neutral oil is equal to or larger than 90%, and the recovery rate of ethyl linoleate is equal to or larger than 80%.
Owner:潘见

Ethyl linoleate catalytically synthesized by using ionic liquid microemulsion and preparation method thereof

The invention belongs to the technical field of preparation of ethyl linoleate, and discloses ethyl linoleate catalytically synthesized by using an ionic liquid microemulsion and a preparation methodthereof. The preparation process comprises the following steps: (1) adding a non-polar solvent into a conventional surfactant, carrying out uniform mixing, dropwise adding imidazole ionic liquid, andcarrying out sufficient mixing to obtain a single ionic liquid microemulsion; and (2) adding linoleic acid and ethanol into the single ionic liquid microemulsion, carrying out a heating reaction, andcarrying out rotary evaporation to obtain ethyl linoleate. According to the method, the single ionic liquid microemulsion with good high-temperature stability is used as a reaction medium, the contactarea of a catalyst and a reaction substrate is increased, and generated water is solubilized in an ionic liquid microemulsion core, so a reaction rate is increased; the used catalyst is high in activity, small in equipment corrosion and low in equipment requirement, the problems of high catalyst cost, serious equipment corrosion, low reaction yield, poor product quality, harsh reaction conditionsand the like in the prior art are solved; and the method can be popularized and applied to catalytic esterification reactions.
Owner:SOUTH CHINA UNIV OF TECH

Lipids and lipids compound used as medicines for treating pain and application method of lipids and lipids compound

The invention discloses lipids and lipids compound used as medicines for treating pain and an application method of the lipids and the lipids compound. The lipids and lipids compound comprise the following lipids compositions including eicosapentaenoic acid ethyl ester (EE-EPA), docosapentaenoic acid ethyl ester (EE-DPA), docosahexaenoic acid ethyl ester (EE-DHA), ethyl linoleate (EE-LA), arachidonic acid ethyl ester (EE-AA), 12-hydroxy eicosanoic acid ethyl ester (EE-12-HETE), linoleic acid (LA), docosahexaenoic acid (DHA), arachidonic acid (AA), eicosapentaenoic acid (DPA) and 12-hydroxy eicosanoic acid (12-HETE), wherein the DPA is all-cis type-7,10,13,16,19-docosapentaenoic acid (DPA) and the like as well as combined application of a variety of lipids; medicines are administered in anoptimal dosage amount in intrathecal, epidural or intranasal ways while combined application of the medicines is allowed, and the medicines can be allowed to repeatedly and continuously administered through the ways, and the medicines directly act upon a central nervous system, so that potential side effects of the medicines and side effects of opiates medicines are reduced as much as possible when the pain is suppressed or prevented by adopting the medicines at the same time.
Owner:崔建国
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products